Why the study?
Atrial giant cell myocarditis has been recognized as a distinct clinicopathological entity from classical giant cell myocarditis, but understanding of its characteristics, triggers, diagnosis, and management remains limited.
Answers are grounded in this paper and cite their sources.
Atrial giant cell myocarditis is a distinct clinicopathological entity characterized by preserved left ventricular function, atrial arrhythmias, and a more benign prognosis than classical giant cell myocarditis.
Giant cell myocarditis (GCM) is a rare and fatal inflammatory disorder induced by T-lymphocytes, typically affecting young adults. Generally, this disease presents with a rapidly progressive course and a very poor prognosis. In recent years, atrial GCM (aGCM) has been recognized as a clinicopathological entity distinct from classical GCM. As described by retrievable case reports, although its histopathological manifestations are highly similar to those of classical GCM, this entity is characterized by preserved left ventricular function and atrial arrhythmias, without ventricular arrhythmias. aGCM tends to show benign disease progression with a better clinical prognosis compared with the rapid course and poor prognosis of vGCM. We report a patient with aGCM with a history of renal abscess whose persistent myocardial injury considered to be associated with a history of renal abscess. Infection could be a potential trigger for the development of aGCM in this patient. An extensive literature review was also performed and the following three aspects were summarized: (1) Epidemiology and histopathological characteristics of aGCM; (2) The role of imaging in the evaluation of aGCM; (3) Diagnostic points and therapeutic decisions in aGCM.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: